{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:52:08Z","timestamp":1790815928893,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicine in Drug Discovery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.medidd.2020.100078","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T13:08:25Z","timestamp":1609333705000},"page":"100078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Emerging peptide antibiotics with therapeutic potential"],"prefix":"10.1016","volume":"9","author":[{"given":"Gregory","family":"Upert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Obrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ermert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medidd.2020.100078_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0015","author":"O\u2019Neill"},{"key":"10.1016\/j.medidd.2020.100078_bb0020","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1016\/j.bmc.2016.09.014","article-title":"New antibiotics from Nature\u2019s chemical inventory","volume":"24","author":"Wencewicz","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","article-title":"Antibiotics in the clinical pipeline in October 2019","volume":"73","author":"Butler","year":"2020","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.medidd.2020.100078_bb0035","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.bmc.2017.08.006","article-title":"Advances in macrocyclic peptide-based antibiotics","volume":"26","author":"Luther","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medidd.2020.100078_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tips.2019.04.012","article-title":"The vast structural diversity of antimicrobial peptides","volume":"40","author":"Koehbach","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24122","article-title":"Antimicrobial peptides under clinical investigation","volume":"111","author":"Koo","year":"2019","journal-title":"Pept Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0055","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10529-018-2589-1","article-title":"Gram-negative bacilli-derived peptide antibiotics developed since 2000","volume":"40","author":"Xue","year":"2018","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.medidd.2020.100078_bb0065","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4155\/fmc-2020-0046","article-title":"Multiple ways to kill bacteria via inhibiting novel cell wall or membrane targets","volume":"12","author":"Naclerio","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4014\/jmb.1804.03051","article-title":"Antimicrobial agents that inhibit the outer membrane assembly machines of gram-negative bacteria","volume":"29","author":"Choi","year":"2019","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.medidd.2020.100078_bb0075","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1182749","article-title":"Peptidomimetic antibiotics target outer-membrane biogenesis in P. aeruginosa","volume":"327","author":"Srinivas","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.medidd.2020.100078_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau2634","article-title":"Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in E. coli","volume":"4","author":"Vetterli","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.medidd.2020.100078_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-019-1665-6","article-title":"Chimeric peptidomimetic antibiotics against Gram-negative bacteria","volume":"576","author":"Luther","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","article-title":"A new antibiotic selectively kills gram-negative pathogens","volume":"576","author":"Imai","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02340-16","article-title":"Intracellular targeting mechanisms by antimicrobial peptides","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molcel.2018.03.001","article-title":"Odilorhabdins, antibacterial agents that cause miscoding by binding at a new ribosomal site","volume":"70","author":"Pantel","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.medidd.2020.100078_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.medidd.2020.100078_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms for antibiotic discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.medidd.2020.100078_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.medidd.2020.100078_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nchembio.1205","article-title":"Systems-level antimicrobial drug and drug synergy discovery","volume":"9","author":"Roemer","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0125","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3389\/fmicb.2018.03177","article-title":"Bacteria of the genus Xenorhabdus, a novel source of bioactive compounds","volume":"9","author":"Dreyer","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0130","series-title":"Novel peptide derivatives as antibiotics","author":"Gualteri","year":"2013"},{"key":"10.1016\/j.medidd.2020.100078_bb0135","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1021\/acs.jmedchem.8b00790","article-title":"Total synthesis and structure\u2013activity relationships study of odilorhabdins, a new class of peptides showing potent antibacterial activity","volume":"61","author":"Sarciaux","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/bbrc.1994.1234","article-title":"Apidaecin-type peptide antibiotics function through a nonporeforming mechanism involving stereospecificity","volume":"199","author":"Casteels","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1039\/C7NP00020K","article-title":"Proline-rich antimicrobial peptides targeting protein synthesis","volume":"34","author":"Graf","year":"2017","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.medidd.2020.100078_bb0150","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00018-011-0721-7","article-title":"Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action","volume":"68","author":"Scocchi","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0155","first-page":"1732","article-title":"Dual mode of action of Bac7, a proline-rich antibacterial peptide","volume":"2006","author":"Podda","year":"1760","journal-title":"Biochim Biophys Acta BBA - Gen Subj"},{"key":"10.1016\/j.medidd.2020.100078_bb0160","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1021\/bi002656a","article-title":"The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding","volume":"40","author":"Kragol","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.medidd.2020.100078_bb0165","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.2174\/092986709789352295","article-title":"The antibacterial effect of a proline-rich antibacterial peptide A3-APO","volume":"16","author":"Rozgonyi","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0170","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.jmb.2013.03.041","article-title":"Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK","volume":"425","author":"Zahn","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/09298665113206660111","article-title":"Structural identification of DnaK binding sites within bovine and sheep bactenecin Bac7","volume":"21","author":"Zahn","year":"2014","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0180","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1002\/anie.201407145","article-title":"Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70 S ribosome","volume":"53","author":"Krizsan","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.medidd.2020.100078_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nsmb.3034","article-title":"The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex","volume":"22","author":"Seefeldt","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0190","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/nar\/gkw018","article-title":"Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition","volume":"44","author":"Gagnon","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.medidd.2020.100078_bb0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nsmb.3031","article-title":"The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin","volume":"22","author":"Roy","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0200","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s13238-017-0495-2","article-title":"Mechanism of actions of Oncocin, a proline-rich antimicrobial peptide, in early elongation revealed by single-molecule FRET","volume":"9","author":"Peng","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.medidd.2020.100078_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2017.00015","article-title":"In vivo efficacy and pharmacokinetics of optimized apidaecin analogs","volume":"5","author":"Schmidt","year":"2017","journal-title":"Front Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0210","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3389\/fmicb.2019.02283","article-title":"Continuous subcutaneous delivery of proline-rich antimicrobial peptide Api137 provides superior efficacy to intravenous administration in a mouse infection model","volume":"10","author":"Knappe","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0215","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jac\/dkv454","article-title":"Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives","volume":"71","author":"Schmidt","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0220","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/bip.22668","article-title":"Oncocin Onc72 is efficacious against antibiotic-susceptible K. pneumoniae ATCC 43816 in a murine thigh infection model: efficacy of Onc72 in susceptible K. pneumoniae ATCC 43816 in thigh infection model","volume":"104","author":"Knappe","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.medidd.2020.100078_bb0225","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/cb300063v","article-title":"Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant gram-negative pathogens","volume":"7","author":"Czihal","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0230","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/iai.57.10.3142-3146.1989","article-title":"Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils","volume":"57","author":"Gennaro","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.medidd.2020.100078_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1910(95)00085-2","article-title":"The inducible antibacterial peptides of the Hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin","volume":"42","author":"Chernysh","year":"1996","journal-title":"J Insect Physiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0240","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/bj3000567","article-title":"Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus","volume":"300","author":"Cociancich","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.medidd.2020.100078_bb0245","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jbiosc.2015.09.002","article-title":"Pyrrhocoricin, a proline-rich antimicrobial peptide derived from insect, inhibits the translation process in the cell-free E. coli protein synthesis system","volume":"121","author":"Taniguchi","year":"2016","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.medidd.2020.100078_bb0250","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1021\/jm100378b","article-title":"Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens","volume":"53","author":"Knappe","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0255","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/jac\/dks241","article-title":"Oncocin derivative Onc72 is highly active against E. coli in a systemic septicaemia infection mouse model","volume":"67","author":"Knappe","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/AAC.47.2.447-457.2003","article-title":"A glutamate mutase is involved in the biosynthesis of the lipopeptide antibiotic friulimicin in actinoplanes friuliensis","volume":"47","author":"Heinzelmann","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0265","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7164\/antibiotics.31.646","article-title":"Isolation of tridecaptins A, B and C. Studies on antibiotics from the genus Bacillus. XXIII","volume":"31","author":"Shoji","year":"1978","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.medidd.2020.100078_bb0270","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1073\/pnas.1608623113","article-title":"Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II","volume":"113","author":"Cochrane","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0275","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/jm401779d","article-title":"Synthesis and structure\u2013activity relationship studies of N-Terminal analogues of the antimicrobial peptide tridecaptin A1","volume":"57","author":"Cochrane","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cbic.201300595","article-title":"Biochemical, structural, and genetic characterization of tridecaptin A1, an antagonist of Campylobacter jejuni","volume":"15","author":"Lohans","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.medidd.2020.100078_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00338-19","article-title":"Tridecaptin M, a new variant discovered in mud bacterium, shows activity against colistin- and extremely drug-resistant Enterobacteriaceae","volume":"63","author":"Jangra","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0290","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1039\/C8CC05790G","article-title":"Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A1","volume":"54","author":"Ballantine","year":"2018","journal-title":"Chem Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0295","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1039\/C7NP00006E","article-title":"Bifunctional antimicrobial conjugates and hybrid antimicrobials","volume":"34","author":"Klahn","year":"2017","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.medidd.2020.100078_bb0300","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1021\/acs.jmedchem.5b01578","article-title":"Synthesis of tridecaptin\u2013antibiotic conjugates with in vivo activity against gram-negative bacteria","volume":"58","author":"Cochrane","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41564-018-0110-1","article-title":"Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant gram-positive pathogens","volume":"3","author":"Hover","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0310","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41564-018-0135-5","article-title":"Discovering antibiotics from the global microbiome","volume":"3","author":"Lam","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202009092","article-title":"Total synthesis of malacidin A by \u03b2-hydroxyaspartic acid ligation-mediated cyclization and absolute structure establishment","author":"Sun","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.medidd.2020.100078_bb0320","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/med.21321","article-title":"Lipopeptides from bacillus and paenibacillus spp.: a gold mine of antibiotic candidates","volume":"36","author":"Cochrane","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.medidd.2020.100078_bb0325","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5694\/j.1326-5377.1970.tb63262.x","article-title":"Acute renal failure due to overdosage of colistin","volume":"2","author":"Brown","year":"1970","journal-title":"Med J Aust"},{"key":"10.1016\/j.medidd.2020.100078_bb0330","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medidd.2020.100078_bb0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/antibiotics8010027","article-title":"A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for gram-negative pneumonia","volume":"8","author":"Biagi","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.medidd.2020.100078_bb0340","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","article-title":"Nephrotoxicity of intravenous colistin: a prospective evaluation","volume":"26","author":"Falagas","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medidd.2020.100078_bb0345","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2008.05.016","article-title":"Pandrug-resistant K. pneumoniae, P. aeruginosa and A. baumannii infections: characteristics and outcome in a series of 28 patients","volume":"32","author":"Falagas","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medidd.2020.100078_bb0350","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: knowns and unknowns","volume":"48","author":"Baron","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medidd.2020.100078_bb0355","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(18)30072-0","article-title":"A colistin crisis in India","volume":"18","author":"Davies","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/antibiotics8030100","article-title":"An approach to measuring colistin plasma levels regarding the treatment of multidrug-resistant bacterial infection","volume":"8","author":"Pacheco","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.medidd.2020.100078_bb0370","doi-asserted-by":"crossref","first-page":"a025288","DOI":"10.1101\/cshperspect.a025288","article-title":"Polymyxin: alternative mechanisms of action and resistance","volume":"6","author":"Trimble","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.medidd.2020.100078_bb0375","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2212activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0380","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ja.2016.146","article-title":"Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections","volume":"70","author":"Brown","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.medidd.2020.100078_bb0385","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4155\/fmc-2016-0091","article-title":"Polymyxins: a new hope in combating Gram-negative superbugs?","volume":"8","author":"Velkov","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0390","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/acsinfecdis.9b00217","article-title":"Design of next generation polymyxins with lower toxicity: the discovery of SPR206","volume":"5","author":"Brown","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0395","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1128\/AAC.02557-14","article-title":"Uptake of polymyxin B into renal cells","volume":"58","author":"Abdelraouf","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0400","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.bmcl.2017.04.027","article-title":"Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria","volume":"27","author":"Becker","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0405","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.chembiol.2018.01.005","article-title":"Structure, function, and biosynthetic origin of octapeptin antibiotics active against extensively drug-resistant gram-negative bacteria","volume":"25","author":"Velkov","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0410","series-title":"Polymyxin Antibiot. Lab. Bench Bedside","first-page":"343","article-title":"Discovery of novel polymyxin-like antibiotics","author":"Velkov","year":"2019"},{"key":"10.1016\/j.medidd.2020.100078_bb0415","series-title":"Carb-X Funds University of Queensland","year":"2020"},{"key":"10.1016\/j.medidd.2020.100078_bb0420","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/jac\/dkt039","article-title":"Novel derivatives of polymyxins","volume":"68","author":"Vaara","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0425","series-title":"Bact. Cell Walls Membr.","first-page":"187","article-title":"Bacterial signal peptidases","volume":"92","author":"Paetzel","year":"2019"},{"key":"10.1016\/j.medidd.2020.100078_bb0430","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1074\/jbc.M401686200","article-title":"Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor","volume":"279","author":"Paetzel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0435","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7164\/antibiotics.55.571","article-title":"Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by streptomyces sp. Tue 6075. II. Structure elucidation","volume":"55","author":"H\u00f6ltzel","year":"2002","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.medidd.2020.100078_bb0440","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1021\/ja2040877","article-title":"Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporus","volume":"133","author":"Liu","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0445","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1074-5521(00)00043-0","article-title":"Biosynthesis of L-p-hydroxyphenylglycine, a non-proteinogenic amino acid constituent of peptide antibiotics","volume":"7","author":"Hubbard","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0450","doi-asserted-by":"crossref","first-page":"15830","DOI":"10.1021\/ja073340u","article-title":"Structural and initial biological analysis of synthetic arylomycin A2","volume":"129","author":"Roberts","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0455","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jacs.8b00087","article-title":"Scalable access to arylomycins via C\u2013H functionalization logic","volume":"140","author":"Peters","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0460","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/AAC.00785-12","article-title":"Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition","volume":"56","author":"Smith","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1107\/S2052252515019971","article-title":"Peptide binding to a bacterial signal peptidase visualized by peptide tethering and carrier-driven crystallization","volume":"3","author":"Ting","year":"2016","journal-title":"IUCrJ"},{"key":"10.1016\/j.medidd.2020.100078_bb0470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/24196","article-title":"Crystal structure of a bacterial signal peptidase in complex with a \u03b2-lactam inhibitor","volume":"396","author":"Paetzel","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0475","doi-asserted-by":"crossref","first-page":"17869","DOI":"10.1021\/ja207318n","article-title":"Synthesis and characterization of the arylomycin lipoglycopeptide antibiotics and the crystallographic analysis of their complex with signal peptidase","volume":"133","author":"Liu","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0480","doi-asserted-by":"crossref","first-page":"36250","DOI":"10.1074\/jbc.M405884200","article-title":"Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I","volume":"279","author":"Kulanthaivel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0485","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/j.bmcl.2013.08.026","article-title":"Efforts toward broadening the spectrum of arylomycin antibiotic activity","volume":"23","author":"Liu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0490","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.chembiol.2010.09.009","article-title":"Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations","volume":"17","author":"Smith","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0495","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.bmcl.2015.07.072","article-title":"The inhibition of type I bacterial signal peptidase: biological consequences and therapeutic potential","volume":"25","author":"Craney","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0500","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1021\/jm1016126","article-title":"Initial efforts toward the optimization of arylomycins for antibiotic activity","volume":"54","author":"Roberts","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0505","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1128\/AAC.00726-12","article-title":"Broadening the spectrum of \u03b2-Lactam Antibiotics through inhibition of signal peptidase type I","volume":"56","author":"Therien","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0510","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-018-0483-6","article-title":"Optimized arylomycins are a new class of Gram-negative antibiotics","volume":"561","author":"Smith","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0515","series-title":"Peptide antibiotic complexes and methods of use thereof","author":"Heise","year":"2020"},{"key":"10.1016\/j.medidd.2020.100078_bb0520","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.9b01174","article-title":"Initial analysis of the arylomycin D antibiotics","author":"Tan","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.medidd.2020.100078_bb0525","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/sojmid\/3\/2\/00133","article-title":"Teixobactin: a new class of antibiotic","volume":"3","author":"Sandle","year":"2015","journal-title":"SOJ Microbiol Infect Dis"},{"key":"10.1016\/j.medidd.2020.100078_bb0535","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1002\/anie.201501440","article-title":"Multiple attack on bacteria by the new antibiotic teixobactin","volume":"54","author":"von Nussbaum","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.medidd.2020.100078_bb0540","article-title":"New antibiotic stirs hope against resistant bacteria","volume":"13","author":"Grady","year":"2015","journal-title":"N Y Times"},{"key":"10.1016\/j.medidd.2020.100078_bb0545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2016.11.002","article-title":"New approaches to antimicrobial discovery","volume":"134","author":"Lewis","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.medidd.2020.100078_bb0550","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fmb-2019-0056","article-title":"Teixobactins: a new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens","volume":"14","author":"Iyer","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14787210.2019.1550357","article-title":"Teixobactin: a novel anti-infective agent","volume":"17","author":"McCarthy","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medidd.2020.100078_bb0560","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/nyas.14282","article-title":"Synthesis and structure\u2212activity relationships of teixobactin","volume":"1459","author":"Karas","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0565","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/AAC.01050-16","article-title":"Dual targeting of cell wall precursors by teixobactin leads to cell lysis","volume":"60","author":"Homma","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0570","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature14193","article-title":"An irresistible newcomer","volume":"517","author":"Wright","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0575","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fmicb.2018.01535","article-title":"In vitro antibacterial activity of teixobactin derivatives on clinically relevant bacterial isolates","volume":"9","author":"Ramchuran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0580","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1039\/C7SC03241B","article-title":"Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding","volume":"8","author":"Parmar","year":"2017","journal-title":"Chem Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0585","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/cbic.201900504","article-title":"Dissecting the binding interactions of teixobactin with the bacterial cell-wall precursor lipid II","volume":"21","author":"Chiorean","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.medidd.2020.100078_bb0590","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1039\/C7CC03415F","article-title":"Alanine scan reveals modifiable residues in teixobactin","volume":"53","author":"Chen","year":"2017","journal-title":"Chem Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0595","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1021\/jacs.8b07709","article-title":"X-ray crystallographic structure of a teixobactin derivative reveals amyloid-like assembly","volume":"140","author":"Yang","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0600","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrd2004","article-title":"Lipid II as a target for antibiotics","volume":"5","author":"Breukink","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.medidd.2020.100078_bb0605","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/AAC.42.9.2215","article-title":"Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms","volume":"42","author":"Marshall","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0610","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1002\/chem.201801423","article-title":"Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against S. aureus, Propionibacterium acnes and P. aeruginosa","volume":"24","author":"Ng","year":"2018","journal-title":"Chem A Eur J"},{"key":"10.1016\/j.medidd.2020.100078_bb0615","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/acs.orglett.6b01324","article-title":"Total Synthesis of Teixobactin","volume":"18","author":"Giltrap","year":"2016","journal-title":"Org Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0620","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.bmc.2017.04.039","article-title":"Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation","volume":"25","author":"Jin","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0625","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschembio.6b00295","article-title":"Elucidation of the teixobactin pharmacophore","volume":"11","author":"Yang","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0630","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C6RA26567G","article-title":"Synthesis and structure\u2013activity relationship studies of teixobactin analogues","volume":"7","author":"Wu","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.medidd.2020.100078_bb0635","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acsomega.6b00354","article-title":"Lysine scanning of Arg 10 \u2013teixobactin: deciphering the role of hydrophobic and hydrophilic residues","volume":"1","author":"Abdel Monaim","year":"2016","journal-title":"ACS Omega"},{"key":"10.1016\/j.medidd.2020.100078_bb0640","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1039\/C5CC10249A","article-title":"Efficient total syntheses and biological activities of two teixobactin analogues","volume":"52","author":"Parmar","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0645","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1039\/C7OB02169K","article-title":"Synthesis and biological evaluation of novel teixobactin analogues","volume":"15","author":"Schumacher","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0650","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1021\/acs.joc.7b02462","article-title":"Thioesterase-mediated synthesis of teixobactin analogues: mechanism and substrate specificity","volume":"83","author":"Mandalapu","year":"2018","journal-title":"J Org Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0655","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1038\/s41467-019-11211-y","article-title":"Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics","volume":"10","author":"Zong","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0660","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/acs.jmedchem.7b01634","article-title":"Design and syntheses of highly potent teixobactin analogues against S. aureus, methicillin-resistant S. aureus (MRSA), and vancomycin-resistant enterococci (VRE) in vitro and in vivo","volume":"61","author":"Parmar","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0665","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1021\/acs.jmedchem.7b01241","article-title":"Developing equipotent teixobactin analogues against drug-resistant bacteria and discovering a hydrophobic interaction between lipid II and teixobactin","volume":"61","author":"Zong","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0670","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1039\/C7CC00783C","article-title":"X-ray crystallographic structure of a teixobactin analogue reveals key interactions of the teixobactin pharmacophore","volume":"53","author":"Yang","year":"2017","journal-title":"Chem Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0675","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/pharmaceutics10040183","article-title":"Cysteines and disulfide-bridged macrocyclic mimics of teixobactin analogues and their antibacterial activity evaluation against methicillin-resistant S. aureus (MRSA)","volume":"10","author":"Malkawi","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.medidd.2020.100078_bb0680","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1021\/acs.jmedchem.7b00834","article-title":"Converting teixobactin into a cationic antimicrobial peptide (AMP)","volume":"60","author":"Abdel Monaim","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0685","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bmc.2011.11.062","article-title":"Studies on the biosynthesis of the lipodepsipeptide antibiotic Ramoplanin A2","volume":"20","author":"Hoertz","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0690","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/cr030106n","article-title":"Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity","volume":"105","author":"Walker","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.medidd.2020.100078_bb0695","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1016\/j.bmcl.2009.09.001","article-title":"Functional and biochemical analysis of a key series of ramoplanin analogues","volume":"19","author":"Fang","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0700","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fmicb.2017.00343","article-title":"Production of ramoplanin and ramoplanin analogs by actinomycetes","volume":"8","author":"de la Cruz","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0705","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.34.3.413","article-title":"Inhibition of peptidoglycan biosynthesis by ramoplanin","volume":"34","author":"Somner","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0710","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/ja000182x","article-title":"A new mechanism of action proposed for ramoplanin","volume":"122","author":"Lo","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0715","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1128\/AAC.00061-14","article-title":"Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in S. aureus","volume":"58","author":"Cheng","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0720","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1021\/bi961017q","article-title":"3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis","volume":"35","author":"Kurz","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.medidd.2020.100078_bb0725","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1021\/ja011080p","article-title":"A new structure for the substrate-binding antibiotic ramoplanin","volume":"123","author":"Lo","year":"2001","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0730","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1021\/ja035217i","article-title":"Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II","volume":"125","author":"Hu","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0735","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1073\/pnas.0904686106","article-title":"A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface","volume":"106","author":"Hamburger","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0740","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.01620-13","article-title":"Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin","volume":"58","author":"Jabes","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0745","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1021\/jm070042z","article-title":"Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplanin","volume":"50","author":"Ciabatti","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0750","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.1021\/ja068573k","article-title":"Alanine scan of [l - Dap2] ramoplanin A2 aglycon: assessment of the importance of each residue","volume":"129","author":"Nam","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0755","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/ja039671y","article-title":"Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity","volume":"126","author":"Rew","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0760","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/ja0212314","article-title":"Total synthesis of the ramoplanin A2 and ramoplanose aglycon","volume":"125","author":"Jiang","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0765","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/ja047879t","article-title":"Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics","volume":"126","author":"Chen","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.medidd.2020.100078_bb0770","series-title":"New lipoglycodepsipeptide compositions","author":"Pelzer","year":"2008"},{"key":"10.1016\/j.medidd.2020.100078_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0000000000000332","article-title":"Novel antibiotics in development to treat Clostridium difficile infection","volume":"33","author":"Bass\u00e8res","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.medidd.2020.100078_bb0780","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fmed.2018.00096","article-title":"Novel antimicrobials for the treatment of clostridium difficile infection","volume":"5","author":"Petrosillo","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.medidd.2020.100078_bb0785","series-title":"Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.medidd.2020.100078_bb0790","series-title":"Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.medidd.2020.100078_bb0795","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/AAC.04853-14","article-title":"Ambush of clostridium difficile spores by ramoplanin: activity in an in vitro model","volume":"59","author":"Kraus","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0800","series-title":"New injectable formulations containing ramoplanin","author":"Parenti","year":"2000"},{"key":"10.1016\/j.medidd.2020.100078_bb0805","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1073\/pnas.93.3.1221","article-title":"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides","volume":"93","author":"Fehlbaum","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.medidd.2020.100078_bb0810","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fmicb.2020.00909","article-title":"Thanatin impairs lipopolysaccharide transport complex assembly by targeting LptC\u2013LptA interaction and decreasing LptA stability","volume":"11","author":"Moura","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0815","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1038\/s41467-019-11503-3","article-title":"The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-\u03b2-lactamase","volume":"10","author":"Ma","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0820","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.peptides.2010.06.009","article-title":"Selective toxicity of antimicrobial peptide S-thanatin on bacteria","volume":"31","author":"Wu","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.medidd.2020.100078_bb0825","doi-asserted-by":"crossref","first-page":"291","DOI":"10.5483\/BMBRep.2002.35.3.291","article-title":"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide","volume":"35","author":"Lee","year":"2002","journal-title":"BMB Rep"},{"key":"10.1016\/j.medidd.2020.100078_bb0830","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.peptides.2012.04.005","article-title":"Subacute toxicity of antimicrobial peptide S-thanatin in ICR mice","volume":"36","author":"Wu","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.medidd.2020.100078_bb0835","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1432-1327.1998.2560404.x","article-title":"Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data","volume":"256","author":"Mandard","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.medidd.2020.100078_bb0840","first-page":"183432","article-title":"NMR structure and localization of the host defense antimicrobial peptide thanatin in zwitterionic dodecylphosphocholine micelle: Implications in antimicrobial activity","volume":"2020","author":"Sinha","year":"1862","journal-title":"Biochim Biophys Acta BBA - Biomembr"},{"key":"10.1016\/j.medidd.2020.100078_bb0845","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41586-019-1039-0","article-title":"Structural basis of unidirectional export of lipopolysaccharide to the cell surface","volume":"567","author":"Owens","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0850","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbpa.2017.02.004","article-title":"Protein epitope mimetic macrocycles as biopharmaceuticals","volume":"38","author":"Luther","year":"2017","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0855","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.ddtec.2011.07.006","article-title":"\u03b2-Hairpin protein epitope mimetic technology in drug discovery","volume":"9","author":"Obrecht","year":"2012","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.medidd.2020.100078_bb0860","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14787210.2018.1441024","article-title":"Murepavadin: a new antibiotic class in the pipeline","volume":"16","author":"Martin-Loeches","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medidd.2020.100078_bb0865","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cbic.201200276","article-title":"Inhibition of lipopolysaccharide transport to the outer membrane in P. aeruginosa by peptidomimetic antibiotics","volume":"13","author":"Werneburg","year":"2012","journal-title":"ChemBioChem"},{"key":"10.1016\/j.medidd.2020.100078_bb0870","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acschembio.7b00822","article-title":"A peptidomimetic antibiotic interacts with the periplasmic domain of LptD from P. aeruginosa","volume":"13","author":"Andolina","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.medidd.2020.100078_bb0875","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/AAC.00390-16","article-title":"Efficacy of the novel antibiotic POL7001 in preclinical models of P. aeruginosa pneumonia","volume":"60","author":"Cigana","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0880","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/092986709787002844","article-title":"Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics","volume":"16","author":"Obrecht","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.medidd.2020.100078_bb0885","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/d41586-019-03730-x","article-title":"New antibiotics target bacterial envelope","volume":"576","author":"Sousa","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0890","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1021\/acs.biochem.9b01086","article-title":"The fellowship of the rings: macrocyclic antibiotic peptides reveal an anti-gram-negative target","volume":"59","author":"McLaughlin","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.medidd.2020.100078_bb0895","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/jac\/dkaa020","article-title":"Antimicrobial activity of POL7306 tested against clinical isolates of gram-negative bacteria collected worldwide","volume":"75","author":"Sader","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0900","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-2370-1","article-title":"Structure of a nascent membrane protein as it folds on the BAM complex","volume":"583","author":"Tomasek","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.medidd.2020.100078_bb0905","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.febslet.2004.10.012","article-title":"Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina","volume":"577","author":"Ovchinnikova","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.medidd.2020.100078_bb0910","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1038\/s41467-020-16950-x","article-title":"An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria","volume":"11","author":"Elliott","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.medidd.2020.100078_bb0915","series-title":"NZ17074: An Arenicin-3 variant found by HTS screening of yeast libraries","author":"Neve","year":"2011"},{"key":"10.1016\/j.medidd.2020.100078_bb0920","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41598-017-03664-2","article-title":"Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against E. coli and Salmonella enteritidis","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.medidd.2020.100078_bb0925","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1007\/s00253-014-5784-6","article-title":"Candidacidal mechanism of the arenicin-3-derived peptide NZ17074 from Arenicola marina","volume":"98","author":"Wang","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.medidd.2020.100078_bb0930","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01056-16","article-title":"Combined systems approaches reveal a multistage mode of action of a marine antimicrobial peptide against pathogenic E. coli and its protective effect against bacterial peritonitis and endotoxemia","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medidd.2020.100078_bb0935","series-title":"Antimicrobial peptide variants and polynucleotides encoding same","author":"Hoegenhaug","year":"2011"},{"key":"10.1016\/j.medidd.2020.100078_bb0940","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/lam.12246","article-title":"Recombinant production of the antimicrobial peptide NZ17074 in Pichia pastoris using SUMO3 as a fusion partner","volume":"59","author":"Wang","year":"2014","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.medidd.2020.100078_bb0945","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fchem.2019.00238","article-title":"Elucidating the lipid binding properties of membrane-active peptides using cyclised nanodiscs","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Chem"}],"container-title":["Medicine in Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590098620300658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590098620300658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:41:13Z","timestamp":1762911673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590098620300658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":189,"alternative-id":["S2590098620300658"],"URL":"https:\/\/doi.org\/10.1016\/j.medidd.2020.100078","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739412378.793584589","asserted-by":"object"}]},"ISSN":["2590-0986"],"issn-type":[{"value":"2590-0986","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging peptide antibiotics with therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Medicine in Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medidd.2020.100078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100078"}}